Note: Ingredients listed on restricted chemical lists
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
238-878-4
Name of the chemical
Quarz-A-Staub (s. u. TRGS 906)
Concentration
N/A
EC/CAS
236-675-5
Name of the chemical
Titandioxid; [in Pulverform mit mindestens 1 % Partikel mit aerodynamischem Durchmesser ≤ 10 μm] (2020/217)
Concentration
N/A
EC/CAS
215-168-2
Name of the chemical
Iron Oxide Red
Concentration
N/A
General Information
Revision date
2017-09-02
Product name
Bauxite Aggregate
supplier name
Meon Ltd
Emergency telephone
+44 (0) 808 118 1922
Icons in SDS
Company Information
company name
Meon Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
mail@meonuk.com
GHS Information
Signal word
No
Section 2
Product definition
UVCB
EU Classification
Classification, Labeling & Packaging Regulation (EC) 1272/2008 Not classified. Ingredients of unknown toxicity Percentage of the mixture consisting of ingredients of unknown toxicity 100% Ingredients of unknown toxicity: Percentage of the mixture consisting of ingredients of unknown hazards to aquatic Directive 67/548/EEC Not classified. See section 16 for the full text of the R phrases or H statements declared above. See section 11 for more detailed information on health effects and symptoms.
Environmental hazards
100%
Hazard pictograms
Not applicable.
Signal word
No signal word
Hazard statements
No known significant effects or critical hazards.
Precautionary statements
Not applicable
2.3 Other hazards
Substance meets the criteria for PBT according to regulation (EC) N° 1907/2006, Annex XIII. Not applicable 1 | 8 Substance meets the criteria for vPvB according to regulation (EC) N° 1907/2006,Annex XIII. Not applicable
Other hazards which do not result in classification
Dust contains respirable crystalline silica. Prolonged and or massive inhalation of respirable crystalline silica dust may cause lung fibrosis, commonly referred to as silicosis. Principal symptoms of silicosis are cough and breathlessness. Occupational exposure to respirable dust should be monitored and controlled. The product should be handled using methods and techniques that minimize or eliminate dust generation. The product contains less than 1 % w/w RCS ( respirable crystalline silica) as determined by the SWERF method. The respirable crystalline silica content can be measured using the “Size- Weighted Respirable Fraction- SWERF” method. All details about the SWERF method is available at www.crystallinesilica.eu .
